Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Ukraine suspends VAT refunds on two Ferrexpo subsidiaries

(Sharecast News) - Ferrexpo said on Friday that Ukrainian tax authorities have suspended VAT refunds for January totalling UAH 512.9m ($12.5m) for two of its subsidiaries, citing sanctions imposed on major shareholder Kostiantyn Zhevago. The FTSE 250 company said the decision affected Ferrexpo Poltava Mining and Ferrexpo Yeristovo Mining.

It emphasised that the sanctions were personal to Zhevago and had not been applied to Ferrexpo itself or any of its subsidiaries.

The company argued that using the sanctions as grounds to withhold VAT refunds would place undue financial pressure on the group, whose majority voting shareholders include international institutional investors.

Ferrexpo warned that the suspension of VAT refunds would add to existing financial strain, amid weak iron ore prices and elevated production costs.

The firm said it expected the move to negatively impact liquidity, leading to lower production and sales volumes.

It also cautioned that it would reduce domestic procurement and result in lower tax, royalty and social contributions to the Ukrainian economy.

"Ferrexpo is a significant contributor to the Ukrainian economy and society, especially during a time of war," said executive chair Lucio Genovese.

"The suspension of VAT refunds will place significant stress on our business, at a time when we are already managing many other challenges.

"Ferrexpo calls on the Ministry of Finance and the State Tax Service of Ukraine to take urgent and effective measures to reinstate the VAT refunds."

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.